KATHRYN LIVELLI

FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and strengthen interagency relationships for national security and emerging pathogen / pandemic preparedness. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines

S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives

FDA reforms including maximized use of AI, improved use of Sentinel, improved IRB processes, and related reforms; working with Rep. Auchincloss, Cline, Griffith, Harder, and Sen Hickenlooper offices to draft legislation. Requested related report language for these issues as well as increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation.